New Webinar: Alternative Strategies to Deliver Bladder Cancer Investigation During COVID-19 and Beyond
UroToday, a high profile news and education portal for urologists, have just released a new webinar focused on Cxbladder. In a discussion led by Neal Shore, MD, two influential urologists discuss their use of Cxbladder’s In-Home Sampling Programme and how it is currently being used by different urologists around the US to streamline patient care.
Many of the tests used to diagnose and detect bladder cancer involve invasive procedures. Non-invasive testing options are equally effective and can be applied in this COVID-19 environment where we want to limit patients needing to come into the clinics for tests. In this discussion Neal Shore, Sima Porten, and Tom Nifong discuss Cxbladder a non-invasive, urine-based laboratory test that measures the gene expression levels of five biomarkers in urine that effectively rule out or detect the presence of bladder cancer. The discussion provides a timely, efficient, and safer method, using Cxbladder to identify at-risk patients for non-muscle invasive bladder cancer (NMIBC) in the at-home setting.« Back